Softwave Tissue Therapy

• SoftWave Therapy is an effective approach to healing the human body using acoustic waves to stimulate your body's natural processes for self-repair.
• This technology is not new. It has been in the marketplace for over 14 years in Europe and just recently FDA cleared in the US.
• There are no known significant negative side effects.
• Inside of the applicator head, SoftWaves are created through the use of an electrode contained within a soft latex dome filled with water. When charged with electricity, the electrode creates a spark under the water. This spark creates a hot bubble of gas that expands into the surrounding water and produces the SoftWave that travels out of the applicator and into the affected area being treated.
• These high energy acoustic waves penetrate deep into damaged tissue resulting in increased mobility and significant reduction, if not complete elimination of inflammation and pain in just the first treatment. Additionally, electrohydraulic shockwaves have proven to have a 300 increase in small, medium and large blood vessels within 12 weeks following the first treatment.
• More importantly, these high energy acoustic waves cause cellular walls to become permeable allowing exosomes to escape into the interstitial tissue mimicking cellular injury which triggers the migration of your body's own stem cells to the area for sustained long-term healing over a 12-week period following the last treatment.
• Not all shockwave therapies are the same. Other companies promote acoustic wave benefits when in fact, most other devices are not true shockwaves. They manufacture a false shockwave which is painful, creates micro trauma to the area and in some cases requires a numbing agent in order for the patient to tolerate the treatment.

SoftWave TRT, LLC was co-founded in 2004 by CEO John Warlick and business partner Mark Gronowski. The two men combined their years of experience in lithotripsy, a medical procedure that uses shock waves to dissolve kidney stones, and the predecessor technology to what we use today for extracorporeal shockwave therapy (ESWT), to form a new company - SoftWave TRT.

SoftWave's purpose was designated to extend the medical use of shockwaves from lithotripsy and urology to nerve and tissue, musculoskeletal pain and injuries, cosmetics and likely many more indications that have yet to be discovered.

SoftWave is sometimes known as stemwave therapy. SoftWave TRT is the first and only supplier of unfocused shockwaves (Li-ESWT_ in North America and continues to research and develop new uses for unfocused shockwave therapy today.

SoftWave TRT is an innovator with a long list of patents.

From chronic non-healing soft tissue wounds to chronic tendinopathies to myofascial syndrome, this technology is changing lives one softwave at a time. The SoftWave team is continually researching, testing, and educating so we can hit our goal of having SoftWave be available to anyone that needs to prevent or heal an injury - because no one should have to settle for living in pain or with a chronic injury. John Warlick, co-founder and CEO

SoftWave has been innovating for decades